Qiagen NV | QIA - Market Capitalization


Qiagen NV reported $7.57B in Market Capitalization this June of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Akebia Therapeutics USD 427M 297M Dec/2025
Alaunos Therapeutics USD 46M 39M Jun/2026
argenx SE USD 44.38B 7.45B Mar/2026
Avita Medical AUD 105.47M 35.32M Dec/2025
Dianthus Therapeutics USD 1.78B 215M Dec/2025
Ionis Pharmaceuticals USD 12.46B 356M Mar/2026
IQVIA Holdings USD 28.63B 9.76B Mar/2026
Moderna USD 20.15B 8.53B Mar/2026
Qiagen NV USD 8.27B 1.62B Mar/2026
Revvity USD 9.94B 1.03B Mar/2026
Tectonic Therapeutic USD 390M 96M Dec/2025
Viatris USD 15.73B 1.39B Mar/2026